A novel BRCA2 mutation in prostate cancer sensitive to combined radiotherapy and androgen deprivation therapy-Reference-Cited by-同舟云学术

A novel BRCA2 mutation in prostate cancer sensitive to combined radiotherapy and androgen deprivation therapy

Published:2018-04-19 Issue:8 Volume:19 Page:669-675
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Liu Qiuli¹^ORCID,Tong Dali¹,Liu Gaolei¹,Yi Yuting²,Xu Jing¹,Yang Xingxia¹,Wang Linang¹,Zhang Jun¹,Ye Jin¹,Zhang Yao¹,Yuan Gang¹,Wang Peng¹,Chen Rongrong²,Guan Yanfang²,Yi Xin²,Zhang Dianzheng³^ORCID,Jiang Jun¹^ORCID

Affiliation:

1. Department of Urology, Daping Hospital/Institute of Surgery Research, Third Military Medical University, Chongqing, China

2. Department of Medical Center, Geneplus-Beijing Institute, Beijing , PR China

3. Department of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine, 4170 City Ave, Philadelphia, PA

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2018.1451278

Reference36 articles.

1. Unravelling the genetics of prostate cancer

2. Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and Finland

3. The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited

4. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

5. BRCA1 and BRCA2: different roles in a common pathway of genome protection

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evolving Landscape of Prostate Cancer Care;Transforming Prostate Cancer Care;2024

2. DNA Damage Repair Pathways in Prostate Cancer: A Narrative Review of Molecular Mechanisms, Emerging Biomarkers and Therapeutic Targets in Precision Oncology;International Journal of Molecular Sciences;2023-07-13

3. Genetic profiling of hormone-sensitive and castration-resistant prostate cancers and identification of genetic mutations prone to castration-resistant prostate cancer;Prostate Cancer and Prostatic Diseases;2022-11-18

4. Combined BRCA2 and MAGEC3 Expression Predict Outcome in Advanced Ovarian Cancers;Cancers;2022-09-28

5. Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches;Molecules;2022-09-05